Table 2b.
Quality control parameters for magnetic resonance spectra determined from LCModel.
CRAMER RAO LOWER BOUND (CRLB) | |||
---|---|---|---|
Thalami | ASD | TD | P |
Cho | 3.95 ± 1.28 | 4.25 ± 2.02 | 0.588 |
Glx | 21.24 ± 10.55 | 21.01 ± 18.83 | 0.798 |
mI | 23.71 ± 11.65 | 18.78 ± 8.52 | 0.081 |
NAA | 6.86 ± 3.90 | 6.75 ± 3.53 | 0.932 |
Cr+PCr | 4.24 ± 1.09 | 4.94 ± 3.77 | 0.423 |
Left DLPFC | |||
Cho | 5.29 ± 2.39 | 5.93 ± 3.39 | 0.606 |
Glx | 15.82 ± 12.10 | 19.95 ± 20.76 | 0.241 |
mI | 14.41 ± 7.23 | 15.29 ± 7.35 | 0.935 |
NAA | 8.41 ± 4.62 | 7.27 ± 3.69 | 0.272 |
Cr+PCr | 4.12 ± 1.90 | 5.00 ± 2.90 | 0.341 |
SIGNAL-TO-NOISE RATIO (SNR) and FULL WIDTH AT HALF MAXIMUM (FWHM) | |||
Thalami | ASD | TD | P |
SNR | 16.59 ± 6.65 | 15.59 ± 6.11 | 0.559 |
FWHM | 0.071 ± 0.018 | 0.077 ± 0.026 | 0.270 |
Left DLPFC | |||
SNR | 15.56 ± 6.35 | 17.75 ± 8.09 | 0.299 |
FWHM | 0.096 ± 0.029 | 0.114 ± 0.043 | 0.105 |
Note: Values reported are mean ± SD. P-values are from Welch two-sample T-test performed between ASD and TD groups. Abbreviations: Cho = choline; Glx = sum of glutamine and glutamate; mI = myo-inositol; NAA = N-acetylaspartate; Cr+PCr = creatine + phosphocreatine.